Lijun Chen

ORCID: 0000-0001-9071-7029
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chronic Myeloid Leukemia Treatments
  • Autophagy in Disease and Therapy
  • Glioma Diagnosis and Treatment
  • Ubiquitin and proteasome pathways
  • Chronic Lymphocytic Leukemia Research
  • RNA modifications and cancer
  • Head and Neck Cancer Studies
  • Genomics, phytochemicals, and oxidative stress
  • Acute Lymphoblastic Leukemia research
  • Science, Research, and Medicine
  • Dietary Effects on Health
  • Mathematical Biology Tumor Growth
  • Oral health in cancer treatment
  • Uterine Myomas and Treatments
  • Infectious Aortic and Vascular Conditions
  • Histone Deacetylase Inhibitors Research
  • HIV/AIDS drug development and treatment
  • Colorectal and Anal Carcinomas
  • Water Treatment and Disinfection
  • HER2/EGFR in Cancer Research
  • Ferroptosis and cancer prognosis
  • Circadian rhythm and melatonin
  • Ocular Oncology and Treatments
  • Aortic aneurysm repair treatments
  • Endometrial and Cervical Cancer Treatments

Guangdong Polytechnic Normal University
2025

Hainan Medical University
2023-2024

Gansu Provincial Hospital
2024

Fujian Provincial Cancer Hospital
2022

Fujian Medical University
2022

Zhuhai People's Hospital
2021

Jinan University
2021

Nanjing Medical University
2019-2020

University of Baltimore
2020

Johns Hopkins University
2020

Copper transporter 1 (CTR1) plays an important role in increasing cisplatin intake. Our previous studies showed that CTR1 expression was upregulated by (-)-epigallocatechin-3-gallate (EGCG), a green tea polyphenol, therefore enhanced sensitivity ovary cancer and non-small-cell lung (NSCLC) cells. In the current study cells, we uncovered potential mechanism of EGCG-induced through its pro-oxidative property. We found EGCG increased reactive oxygen species (ROS) generation, while presence ROS...

10.1002/jcp.29451 article EN Journal of Cellular Physiology 2020-01-14

10.1016/j.cam.2024.116464 article EN Journal of Computational and Applied Mathematics 2025-01-01

The emergence of castration-resistance is one the major challenges in management patients with advanced prostate cancer. Although spectrum systemic therapies that are available for use alongside androgen deprivation treatment castration-resistant cancer (CRPC) expanding, none these regimens curative. Therefore, it imperative to apply systems approaches identify and understand mechanisms contribute development CRPC. Using comprehensive proteomic approaches, we show a glycosylation-related...

10.3390/cancers12020468 article EN Cancers 2020-02-18

Abstract Mitofusin 2 (MFN2) has been found to be downregulated in patients with Alzheimer disease (AD) but little is known about its roles the pathogenesis of AD. We explored mechanism N6-methyladenosine (m6A) methylation Mfn2 hippocampal mitochondrial dysfunction an AD mouse model. APP/PS1 transgenic mice underwent stereotaxic injection adeno-associated viruses and their behaviors were assessed. METTL3 MFN2 expressions measured by qRT-PCR Western blot, accompanied assessment morphology,...

10.1093/jnen/nlae010 article EN Journal of Neuropathology & Experimental Neurology 2024-02-26

In brief Preeclampsia is a pregnancy complication that can lead to severe adverse maternal and fetal outcomes, but the mechanisms underlying development of preeclampsia are not fully understood. This study shows ETV4 plays an essential role in proliferation, invasion, migration trophoblast cells by regulating MMP-2 MMP-9 involved pathogenesis preeclampsia. Abstract (PE) outcomes. However, PE ETS Variant Transcription Factor 4 (ETV4) important cell migration, invasion. this study, we aimed...

10.1530/rep-22-0184 article EN Reproduction 2023-01-30

Temozolomide resistance is a major cause of recurrence and poor prognosis in neuroglioma. Recently, growing evidence has suggested that mitophagy involved drug various tumor types. However, the role molecular mechanisms temozolomide glioma remain unclear. In this study, levels temozolomide-resistant -sensitive cell lines were evaluated. The underlying regulation explored through RNA sequencing, roles differentially expressed genes investigated. We found promotes glioma. Specifically, small...

10.31857/s0026898424010112 article EN Молекулярная биология 2024-02-15

OBJECTIVE To investigate the effects of uroacitide (CDA-2), a cell differentiation agent, on growth inhibition and imatinib-(IM) resistant chronic myeloid leukemia (CML) cells. METHODS IM CML line K562R was established from K562. K562 cells were cultured with CDA-2 different concentrations. MTI method used to detect survival rates. Bone marrow IM-resistant non-IM-resistant patients collected co-incubated MTT colony-forming assays evaluate efficacy treatment for in lines, or bone patients;...

10.3760/j.issn:0376-2491.2007.48.004 article EN 2007-12-25

Objective: This study aimed to identify a subset of patients with stage IA2 IIA2 cervical cancer who are at low risk lymph node metastasis (LNM) using pathological parameters including estrogen receptor alpha (ERα) and progesterone (PR). Methods: The clinical data underwent radical surgery between 2014 2015 were retrospectively reviewed. Immunohistochemical staining was used determine the expression ERα PR. A low-risk criterion for LNM identified logistic regression analysis, its performance...

10.2147/cmar.s343518 article EN cc-by-nc Cancer Management and Research 2022-01-01

Abstract Patients with head and neck squamous cell carcinomas (HNSCCs) are treated surgery, radiation, chemotherapy, limited targeted therapies. Compared to human papillomavirus (HPV)-positive HNSCCs, HPV-negative cases have worse treatment response prognosis represent an unmet clinical need. We performed comprehensive proteogenomic characterization of tumor specimens, matched normal adjacent tissues (NATs), blood samples from 109 HNSCC patients. This cohort is dominated by tumors oral...

10.1158/1538-7445.am2020-5118 article EN Cancer Research 2020-08-15
Coming Soon ...